| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | STIM | Neuronetics, Inc. Ordinary Stock | Other | -287K | -9.16% | 2.84M | Jun 1, 2023 | By partnerships and separately-managed accounts | F1, F2, F3, F4, F5 |
| Id | Content |
|---|---|
| F1 | There is no applicable price since this transaction is the result of a termination of an investment agreement. See footnote 5. |
| F2 | As of June 1, 2023, Tonga Partners, LP, Tristan Partners, LP, and Tristan Offshore Fund, Ltd., and sundry separately-managed accounts advised by Cannell Capital LLC (collectively the "Cannell Investment Vehicles") owned in the aggregate 2,841,223 shares of the common stock of Neuronetics, Inc. |
| F3 | Cannell Capital LLC acts as the general partner of and investment adviser to Tonga Partners, LP, and Tristan Partners, L.P. and as the investment adviser to the Tristan Offshore Fund, Ltd and the sundry separately-managed accounts. J. Carlo Cannell is the sole managing member of Cannell Capital LLC. As such, Mr. Cannell possesses sole power to vote and direct the disposition of all securities of Neuronetics, Inc. held by the Cannell Investment Vehicles. Thus, for the purposes of Reg. Section 240.13d-3, as of June 1, 2023, Mr. Cannell beneficially owned 2,841,223 shares. Mr. Cannell's interest in the securities reported herein is limited to the extent of his pecuniary interest in each of the Cannell Investment Vehicles, if any. |
| F4 | The investment vehicles for which transactions are reported herein have a performance fee that does not give rise to reportable pecuniary interest pursuant to the exemption set forth in Rule 16a-1(a)(2)(ii)(C), and Mr. Cannell and Cannell Capital LLC accordingly disclaim pecuniary interest in the reported transactions in accordance with the same. |
| F5 | Cannell Capital LLC files this Form 4 to reflect its reduced ownership as of June 1, 2023 due to the termination of an investment agreement between Cannell Capital LLC and a separately-managed account. Said account held 286,596 shares of the common stock of Neuronetics, Inc. prior to termination. |